A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults

NCT07261371 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Test formulation (Treatment A)
DRUG: Reference formulation (Treatment B)
DRUG: Test formulation (Treatment C)
DRUG: Test formulation (Treatment D)

Sponsor

Pfizer